Is Montelukast Benefical in Children With Atopic Dermatitis?
Author:
Open Access
- 1 January 2016
- journal article
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 8 (4) , 279-281
Abstract
Lee AY. Allergy Asthma Immunol Res. 2016 Jul;8(4):279-281. http://dx.doi.org/10.4168/aair.2016.8.4.279Keywords
Funding Information
- National Research Foundation of Korea (NRF-2014R1A2A2A09051812)
This publication has 19 references indexed in Scilit:
- A Double-Blind, Randomized, Crossover Study to Compare the Effectiveness of Montelukast on Atopic Dermatitis in Korean ChildrenAllergy, Asthma & Immunology Research, 2016
- Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic reviewJournal of Allergy and Clinical Immunology, 2014
- Atopic dermatitis: a disease of altered skin barrier and immune dysregulationImmunological Reviews, 2011
- “Outside-to-Inside” (and Now Back to “Outside”) Pathogenic Mechanisms in Atopic DermatitisJournal of Investigative Dermatology, 2008
- A double‐blind, placebo‐controlled trial of montelukast in adult atopic eczemaClinical & Experimental Allergy, 2007
- Montelukast treatment of moderate to severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled trialJournal of the American Academy of Dermatology, 2005
- Efficacy and Tolerability of Montelukast as a Therapeutic Agent for Severe Atopic Dermatitis in AdultsActa Dermato-Venereologica, 2002
- Leukotriene receptor antagonist therapyPostgraduate Medical Journal, 2000
- Tolerability of MontelukastDrugs, 2000
- Leukotriene C: a slow-reacting substance from murine mastocytoma cells.Proceedings of the National Academy of Sciences, 1979